Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-16 Purchase |
2021-03-18 5:11 pm |
Marker Therapeutics Inc. | MRKR | Behbahani Ali 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:09 pm |
Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-09-18 Purchase |
2020-09-22 5:42 pm |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
769,230 | $13 | $9,999,990 | 3,060,527 (Indirect) |
View |
| 2020-07-24 Purchase |
2020-07-28 5:22 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner |
3,151,260 | $2.25 | $7,090,335 | 13,528,196 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-01 5:49 pm |
Akouos Inc. | AKUS | Behbahani Ali 10% Owner |
588,235 | $17 | $9,999,995 | 4,294,207 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-10 Option Award |
2021-06-14 6:23 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:52 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
8,665 | $0 | 15,265 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-22 8:33 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
547 | $24.01 | 3,449,304 (Direct) |
View |
Ownership |
2021-03-16 6:29 pm |
N/A N/A |
Savara Inc | SVRA | Behbahani Ali 10% Owner |
0 | $0 | 24,137,931 (Indirect) |
View |
| 2020-09-18 Conversion |
2020-09-22 5:42 pm |
N/A N/A |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
2,291,297 | $0 | 3,060,527 (Indirect) |
View |
Ownership |
2020-09-15 5:25 pm |
N/A N/A |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
0 | $0 | 2,291,297 (Indirect) |
View |
| 2020-08-13 Other |
2020-08-14 4:30 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
71 | $0 | 341 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 9:47 pm |
N/A 2030-07-08 |
Nkarta Inc. | NKTK | Behbahani Ali Director |
10,700 | $0 | 10,700 (Direct) |
View |
| 2020-06-30 Conversion |
2020-07-01 5:49 pm |
N/A N/A |
Akouos Inc. | AKUS | Behbahani Ali 10% Owner |
3,705,972 | $0 | 4,294,207 (Indirect) |
View |
| 2020-07-01 Option Award |
2020-07-01 5:13 pm |
2021-07-01 2030-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
184,258 | $0 | 184,258 (Direct) |
View |
Ownership |
2020-06-25 7:16 pm |
N/A N/A |
Akouos Inc. | AKUS | Behbahani Ali 10% Owner |
0 | $0 | 3,705,972 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-06-19 7:38 pm |
2021-06-18 2030-06-18 |
GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 7:49 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 9:17 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
6,600 | $0 | 6,600 (Direct) |
View |